SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-214949
Filing Date
2020-08-10
Accepted
2020-08-10 16:23:18
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d945496d10q.htm 10-Q 569489
2 EX-31.1 d945496dex311.htm EX-31.1 7471
3 EX-31.2 d945496dex312.htm EX-31.2 7430
4 EX-32.1 d945496dex321.htm EX-32.1 4460
  Complete submission text file 0001193125-20-214949.txt   4319402

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT orgo-20200630.xml EX-101.INS 777489
6 XBRL TAXONOMY EXTENSION SCHEMA orgo-20200630.xsd EX-101.SCH 47566
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20200630_cal.xml EX-101.CAL 52326
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20200630_def.xml EX-101.DEF 262347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20200630_lab.xml EX-101.LAB 393179
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20200630_pre.xml EX-101.PRE 348568
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 201089685
SIC: 2834 Pharmaceutical Preparations